Request Sample Inquiry
Synthetic Biology Market

Synthetic Biology Market

Synthetic Biology Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

173

Base Year:

2022

Date

Jan - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1255

Segments Covered
  • By Tool By Tool Enzymes, Synthetic Cells, Oligonucleotides and Synthetic DNA, Cloning Technology Kits, Xeno-nucleic Acids, Chassis Organisms
  • By Technology By Technology Sequencing, Cloning, Gene Synthesis, Genome Engineering, Bioinformatics, Microfluidics, Nanotechnology, Site-directed Mutagenesis, Measurement and Modelling
  • By Application By Application Medical Application, Industrial Application, Environmental Application, Artificial Tissue and Tissue Regeneration, Food and Agriculture
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 12.70 Billion
Revenue 2030Revenue 2030: USD 85.97 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 27.00%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
Synthetic Biology Market Share

Market Synopsis:

Global Synthetic Biology Market is valued at USD 12.70 Billion in 2022 and is projected to attain a value of USD 85.97 Billion by 2030 at a CAGR of 27.00% during the forecast period, 2022–2028. Living materials, biocomputing, therapeutic genome editing, living biotherapeutics, multiplexed diagnostics and cellular recording, electrical interfacing, and third-generation biorefineries have all benefited from Synthetic Biology advancements in recent years. Agriculture, pharmaceutical, and biotechnology industries have been able to generate synthetic biology products thanks to advances in genome editing, gene circuit design, metagenomic discovery, automated strain engineering, directed evolution, and metabolic engineering. Chemicals produced by altered cells/enzymes, such as genome-edited soy, CAR-Ts, and engineered bacteria, include diamines, sitagliptin, and leghemoglobin.

Synthetic Biology Market Size, 2022 To 2030 (USD Billion)

AI (GPT) is here !!! Ask questions about Synthetic Biology Market
Loading....

The growing population and changing eating habits, combined with resource scarcity, have aided nutrition research and development. Synthetic Biology has helped to identify a number of good food production technologies. The technology is projected to aid in the generation of higher food yields and the advancement of pest management techniques.

Rising R&D Funding and Growing Initiatives in Synthetic Biology

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

  • Real-Time Data Updates:
  • Competitor Benchmarking
  • Market Trends Heatmap
  • Custom Research Queries
  • Market Sentiment Analysis
  • Demographic and Geographic Insights

Get Access Now

Due to extended research times and approval delays, the R&D business has always been capital-intensive. R&D is recognised by governments as a critical investment for a country's prosperity, international competitiveness, and public benefit. As a result, R&D spending and funding have steadily increased throughout the years. According to Business Wire (September 2020), the life sciences industry's R&D spending increased by 22% from 2018 to 2019. Pharmaceutical and biotechnology businesses spend a lot of money on research in order to produce breakthrough compounds that will meet the expanding demands of the healthcare industry and fight new ailments. The global pharmaceutical R&D sector contributes for over 80% of the life sciences industry's total R&D spending.

Biosafety, biosecurity, and ethical concerns

The purposeful or unintended release of synthetic organisms into the environment during research and other uses is a major biosafety risk in Synthetic Biology. When synthetic microorganisms are released into the environment, they can mutate or interact with other species, leading to crossbreeding and bio errors. This may put natural species' ecosystems in jeopardy. Another major biosafety worry is the emergence of antibiotic-resistant superbugs. The European Union (EU) has recently supported various studies into the environmental impact of genetically modified bacteria released for plant growth or bioremediation.

Market Segmentation:

The Global Synthetic Biology Market has been segmented by Product (Core Products and Enabling Products, Enabled products), Application (Healthcare, Chemicals (Including Bio-Fuels), Food and Agriculture, Other Applications (Biosecurity, Energy, and Environment). Based on Region, the Synthetic Biology Market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Below tree is interactive. You can click the nodes to get more information.

North America to Continue Dominating the Synthetic Biology Market

North America, and Europe accounted for the largest proportion of the Synthetic Biology Market in 2020. Factors such as the increase in the number of well-established Synthetic Biology companies and research institutes in the United States and Canada, a large number of ongoing research studies, and the overall growth of the healthcare sector on a global scale are among the few factors expected to contribute to the market's growth. One of the primary causes leading to the growing demand for Synthetic Biology techniques and technologies among academic and research organisations, as well as healthcare firms in North America, is increased R&D spending.

Key Players:

Key players in the synthetic biology market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen, Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), and Eurofins Scientific (Luxembourg).

Synthetic Biology Market is segmented as follows:

Parameter Details
Segments Covered
  • Tool (Enzymes, Synthetic Cells, Oligonucleotides and Synthetic DNA, Cloning Technology Kits, Xeno-nucleic Acids, Chassis Organisms)
  • Technology (Sequencing, Cloning, Gene Synthesis, Genome Engineering, Bioinformatics, Microfluidics, Nanotechnology, Site-directed Mutagenesis, Measurement and Modelling)
  • Application (Medical Application, Industrial Application, Environmental Application, Artificial Tissue and Tissue Regeneration, Food and Agriculture)
  • Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • Thermo Fisher Scientific Inc. (US)
  • Merck KGaA (Germany)
  • Agilent Technologies Inc. (US)
  • Novozymes A/S (Denmark)
  • Ginkgo Bioworks (US)
  • Amyris (US)
  • Precigen Inc. (US)
  • GenScript (China)
  • Twist Bioscience (US)
  • Synthetic Genomics (US)
  • Codexis (US)
  • Synthego (US)
  • Creative Enzymes (US)
  • Eurofins Scientific (Luxembourg)
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis
Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Explore purchase options

Synthetic Biology Market is tabulated as follows:

FAQ
Frequently Asked Question
  • The global Synthetic Biology valued at USD 12.70 Billion in 2022 and is expected to reach USD 85.97 Billion in 2030 growing at a CAGR of 27.00%.

  • The prominent players in the market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen, Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), Eurofins Scientific (Luxembourg).

  • The market is project to grow at a CAGR of 27.00% between 2023 and 2030.

  • The driving factors of the Synthetic Biology include

    • Rising R&D Funding and Growing Initiatives in Synthetic Biology

  • North America was the leading regional segment of the Synthetic Biology in 2022.

Related Reports